...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Reports Of Exempt Distribution.

"KK2 - Zenith Capital Corp is a non-trading public company. I would check the rules before making any assumptions on blackouts and the rules around them"

Ya that's usually a good idea before stating things as fact! 

Share
New Message
Please login to post a reply